SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-056196
Filing Date
2021-11-10
Accepted
2021-11-10 16:12:58
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cccc-8k_20211110.htm   iXBRL 8-K 43902
2 EX-99.1 cccc-ex991_56.htm EX-99.1 157848
3 GRAPHIC g2y1cmu1kf3a000001.jpg GRAPHIC 7489
  Complete submission text file 0001564590-21-056196.txt   357614

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cccc-20211110.xsd EX-101.SCH 5693
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cccc-20211110_lab.xml EX-101.LAB 20078
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cccc-20211110_pre.xml EX-101.PRE 11940
7 EXTRACTED XBRL INSTANCE DOCUMENT cccc-8k_20211110_htm.xml XML 3674
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 211396727
SIC: 2836 Biological Products, (No Diagnostic Substances)